CLEARASIL STUBBORN ACNE CONTROL 5IN1 WEEKLY SCRUB- salicylic acid lotion 
RB Health (US) LLC

----------

Clearasil ®Stubborn Acne Control 5in1 Weekly Scrub

Drug Facts

Active ingredient

Salicylic acid 2%

Purpose

Acne medication

Use

for the treatment of acne

Warnings

For external use only

When using this product

  • avoid contact with the eyes. If product gets into the eyes, rinse thoroughly with water.
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • limit use to the face and neck

Stop use and ask a doctor ifskin or eye irritation develops

Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • wet face
  • dispense product into hands, lather and massage gently onto face and neck, avoiding the delicate eye area
  • rinse thoroughly with warm water one to three times daily
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
  • if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Other information

  • keep tightly closed
  • store in a cool, dry place

Inactive ingredients

Water, Sodium Cocoyl Isethionate, Glycerin, Cetyl Alcohol, Laureth-3, Sodium Laureth Sulfate, Hydrated Silica, Niacinamide, Sodium Lactate, Sodium Cocoamphoacetate, Sorbitol, Hexyldecanol, Sodium Chloride, Fragrance, Sodium Hydroxide, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Disodium EDTA, Bisabolol, Dipotassium Glycyrrhizinate, Benzyl Salicylate, Brassica Campestris (Rapeseeed) Sterols, Cetylhydroxyproline Palmitamide, Stearic Acid, Polyquaternium-43, Phenoxyethanol, Sodium Benzoate, Sodium Sulfate, FD&C Blue 1, FD&C Yellow 6

Questions?

1-866-25-CLEAR (1-866-252-5327).

You may also report side effects to this phone number.

Distributed by: RB Health (US),
Parsippany, NJ 07054-0224
Made in Brazil

PRINCIPAL DISPLAY PANEL - 150 mL Tube Label

Clearasil ®

STUBBORN ACNE
CONTROL 5IN1

WEEKLY SCRUB

Salicylic Acid Acne Medication

FIGHTS
5
STUBBORN
ACNE
PROBLEMS

FIGHTS 1. BLOCKED PORES 2. PIMPLE SIZE
3. EXCESS OIL 4. ACNE MARKS 5. BLACKHEADS

5 fl oz (150 mL)

PRINCIPAL DISPLAY PANEL - 150 mL Tube Label
CLEARASIL STUBBORN ACNE CONTROL 5IN1 WEEKLY SCRUB 
salicylic acid lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63824-441
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID2 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
SODIUM COCOYL ISETHIONATE (UNII: 518XTE8493)  
GLYCERIN (UNII: PDC6A3C0OX)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
LAURETH-3 (UNII: F32E4CB0UJ)  
SODIUM LAURETH-3 SULFATE (UNII: BPV390UAP0)  
HYDRATED SILICA (UNII: Y6O7T4G8P9)  
NIACINAMIDE (UNII: 25X51I8RD4)  
SODIUM LACTATE (UNII: TU7HW0W0QT)  
SODIUM COCOAMPHOACETATE (UNII: W7Q5E87674)  
SORBITOL (UNII: 506T60A25R)  
HEXYLDECANOL (UNII: 151Z7P1317)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) (UNII: 59TL3WG5CO)  
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
LEVOMENOL (UNII: 24WE03BX2T)  
GLYCYRRHIZINATE DIPOTASSIUM (UNII: CA2Y0FE3FX)  
BENZYL SALICYLATE (UNII: WAO5MNK9TU)  
RAPESEED STEROL (UNII: B46B6DD20U)  
CETYLHYDROXYPROLINE PALMITAMIDE (UNII: 74ONU0S62G)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
SODIUM SULFATE (UNII: 0YPR65R21J)  
FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63824-441-01150 mL in 1 TUBE; Type 0: Not a Combination Product12/01/201705/01/2023
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00612/01/201705/01/2023
Labeler - RB Health (US) LLC (081049410)

Revised: 10/2023
 
RB Health (US) LLC